113 related articles for article (PubMed ID: 23176400)
21. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer.
Ucar E; Semerci E; Ustun H; Yetim T; Huzmeli C; Gullu M
Adv Ther; 2008 Oct; 25(10):1075-84. PubMed ID: 18821070
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of combination assays for CEA and CA 19-9 in gastric cancer.
Ikeda Y; Oomori H; Koyanagi N; Mori M; Kamakura T; Minagawa S; Tateishi H; Sugimachi K
Oncology; 1995; 52(6):483-6. PubMed ID: 7478435
[TBL] [Abstract][Full Text] [Related]
23. Serum levels of interleukin-2 and tumor necrosis factor-alpha correlate to tumor progression in gastric cancer.
Forones NM; Mandowsky SV; Lourenço LG
Hepatogastroenterology; 2001; 48(40):1199-201. PubMed ID: 11490833
[TBL] [Abstract][Full Text] [Related]
24. Correlation between positive CA 72-4 serum levels and lymph node involvement in patients with gastric carcinoma.
Guadagni F; Roselli M; Cosimelli M; Ferroni P; Spila A; Casaldi V; Cavaliere F; Carlini M; Garofalo A; Rinaldi G
Anticancer Res; 1993; 13(6B):2409-13. PubMed ID: 8135475
[TBL] [Abstract][Full Text] [Related]
25. Receiver operating characteristic (ROC) curve analysis of the tumor markers CEA, CA 19-9 and CA 72-4 in gastric cancer.
Fernández-Fernández L; Tejero E; Tieso A; Rabadán L; Munoz M; Santos I
Int Surg; 1996; 81(4):400-2. PubMed ID: 9127805
[TBL] [Abstract][Full Text] [Related]
26. Combined preoperative concentrations of CEA, CA 19-9, and 72-4 for predicting outcomes in patients with gastric cancer after curative resection.
Liu X; Qiu H; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z; Sun X
Oncotarget; 2016 Jun; 7(23):35446-53. PubMed ID: 27147574
[TBL] [Abstract][Full Text] [Related]
27. [Changes in tumor markers CEA, Ca 19-9 and Ca 125 in monitoring of response to chemotherapy in elderly patients with advanced gastric cancer].
Caponetti R; Caponetti T; Vici P
Clin Ter; 2002; 153(6):373-5. PubMed ID: 12645392
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer.
Fujimura T; Kinami S; Ninomiya I; Kitagawa H; Fushida S; Nishimura G; Kayahara M; Shimizu K; Ohta T; Miwa K
Endoscopy; 2002 Jul; 34(7):569-74. PubMed ID: 12170412
[TBL] [Abstract][Full Text] [Related]
29. The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment.
Li F; Li S; Wei L; Liang X; Zhang H; Liu J
Biomarkers; 2013 Nov; 18(7):632-7. PubMed ID: 24066812
[TBL] [Abstract][Full Text] [Related]
30. Preoperative prediction of peritoneal metastasis in gastric cancer as an indicator for neoadjuvant treatment.
Ohi M; Mori K; Toiyama Y; Mohri Y; Okigami M; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Kusunoki M
Anticancer Res; 2015 Jun; 35(6):3511-8. PubMed ID: 26026118
[TBL] [Abstract][Full Text] [Related]
31. Elevated serum synuclein-gamma in patients with gastrointestinal and esophageal carcinomas.
Liu C; Ma H; Qu L; Wu J; Meng L; Shou C
Hepatogastroenterology; 2012 Oct; 59(119):2222-7. PubMed ID: 22440249
[TBL] [Abstract][Full Text] [Related]
32. Clinical validity of tissue carcinoembryonic antigen expression as ancillary to serum carcinoembryonic antigen concentration in patients curatively resected for colorectal cancer.
Park JW; Chang HJ; Kim BC; Yeo HY; Kim DY
Colorectal Dis; 2013 Sep; 15(9):e503-11. PubMed ID: 23711333
[TBL] [Abstract][Full Text] [Related]
33. Atypical courses of serum tumor markers--4 case reports.
Klapdor R; Bahlo M; Babinski A
Anticancer Res; 2003; 23(2A):845-50. PubMed ID: 12820311
[TBL] [Abstract][Full Text] [Related]
34. Pre-operative serum levels of sialyl Tn antigen predict liver metastasis and poor prognosis in patients with gastric cancer.
Nakagoe T; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K; Ishikawa H
Eur J Surg Oncol; 2001 Dec; 27(8):731-9. PubMed ID: 11735169
[TBL] [Abstract][Full Text] [Related]
35. Elevated levels of serum tumor markers CA 15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancers.
Lee JS; Park S; Park JM; Cho JH; Kim SI; Park BW
Breast Cancer Res Treat; 2013 Oct; 141(3):477-84. PubMed ID: 24072270
[TBL] [Abstract][Full Text] [Related]
36. Serological studies on CEA, CA 19-9, STn and SLX in colorectal cancer.
Sato T; Nishimura G; Nonomura A; Miwa K; Miyazaki I
Hepatogastroenterology; 1999; 46(26):914-9. PubMed ID: 10370638
[TBL] [Abstract][Full Text] [Related]
37. The prognostic value of preoperative serum levels of CEA and CA19-9 in patients with gastric cancer.
Kodera Y; Yamamura Y; Torii A; Uesaka K; Hirai T; Yasui K; Morimoto T; Kato T; Kito T
Am J Gastroenterol; 1996 Jan; 91(1):49-53. PubMed ID: 8561143
[TBL] [Abstract][Full Text] [Related]
38. Impact of preoperative serum carcinoembryonic antigen, CA 19-9 and alpha fetoprotein levels in gastric cancer patients.
Nakajima K; Ochiai T; Suzuki T; Shimada H; Hayashi H; Yasumoto A; Takeda A; Hishikawa E; Isono K
Tumour Biol; 1998; 19(6):464-9. PubMed ID: 9817974
[TBL] [Abstract][Full Text] [Related]
39. [The role of tumor markers in diagnosing metastases of gastric cancer: preoperative diagnostics (part I)].
Kurygin AA; Maĭstrenko NA; Khrykov GN; Beliak NP
Vestn Khir Im I I Grek; 2009; 168(4):16-9. PubMed ID: 19947409
[TBL] [Abstract][Full Text] [Related]
40. Serum CA 19-9, SLX, STN and CEA levels of the peripheral and the draining venous blood in gastric cancer.
Imada T; Rino Y; Takahashi M; Hatori S; Shiozawa M; Amano T; Kondo J
Hepatogastroenterology; 1999; 46(27):2086-90. PubMed ID: 10430402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
